
Kimberly-Clark (KMB) Stock Forecast & Price Target
Kimberly-Clark (KMB) Analyst Ratings
Bulls say
Kimberly-Clark maintains a strong market position in the tissue and hygiene sector, with more than half of its sales derived from personal care products and an additional third from consumer tissue offerings. The company plans to leverage a robust innovation pipeline in 2026, which is expected to enhance its competitive edge and allow for technological advancements to be cascaded across product tiers. With a diverse geographic sales distribution—over 50% in North America and significant portions in Europe, Asia, and Latin America—Kimberly-Clark is well-positioned to capitalize on growth opportunities across multiple markets.
Bears say
Kimberly-Clark is experiencing a significant downturn, with a projected -4.0% decline in organic sales for the third quarter of 2025, impacting its overall growth outlook. Additionally, the company has reported a -2.7% decrease in US measured retail sales year-to-date for the same period. Consequently, earnings per share (EPS) estimates have been revised downward, with projections for fiscal year 2025 adjusted from $7.60 to $7.41 and for 2026 adjusted from $8.00 to $7.85, indicating ongoing financial challenges.
This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.
Kimberly-Clark (KMB) Analyst Forecast & Price Prediction
Start investing in Kimberly-Clark (KMB)
Order type
Buy in
Order amount
Est. shares
0 shares